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Objective. To study temporal trends of hysterectomy routes performed for uterine cancer and their associations with body mass
index (BMI) and perioperative morbidity. Methods. A retrospective review of the American College of Surgeons-National Surgical
Quality Improvement Program (ACS-NSQIP) 2005-2013 databases was conducted. All patients who were 18 years old and older
with a diagnosis of uterine cancer and underwent hysterectomy were identified using ICD-9-CM and CPT codes. Surgical route was
classified into four groups: total abdominal hysterectomy (TAH), total vaginal hysterectomy (TVH), laparoscopic assisted vaginal
hysterectomy (LAVH), and total laparoscopic hysterectomy (TLH) including both conventional and robotically assisted. Patients
were then stratified according to BMI. Results. 7199 records were included in the study. TLH was the most commonly performed
route of hysterectomy regardless of BMI, with proportions of 50.9%, 48.9%, 50.4%, and 51.2% in ideal, overweight, obese, and
morbidly obese patients, respectively. The median operative time for TAH was 2.2 hours compared to 2.7 hours for TLH (𝑝 < 0.01).
The median length of stay for TAH was 3 days compared to 1 day for TLH (𝑝 < 0.01). The percentage of patients with an adverse
outcome (composite indicator including transfusion, deep venous thrombosis, and infection) was 17.1 versus 3.7 for TAH and TLH,
respectively (𝑝 < 0.01). Conclusion. During the last decade, TLH has been increasingly performed in women with uterine cancer.
The increased adoption of TLH was seen in all BMI subgroups.

1. Introduction
Uterine cancer is the most common gynecologic cancer
in USA [1], with the median age at presentation being
60 years [2]. Depending on the stage and grade, surgery
is the mainstay of treatment of uterine tumors, with or
without subsequent radiation. Early stage uterine cancer can
be managed safely with conventional as well as robotically
assisted laparoscopic approaches [3, 4].
Despite the evidence-based benefits associated with minimally invasive gynecologic surgical approaches, laparotomy
remains the route of choice in more than 60% of the 600,000
hysterectomy procedures performed annually in USA [5].
The rate of abdominal hysterectomy in USA between 2003

and 2005 was still over 60% and only 12–14% of hysterectomies were being performed laparoscopically [6].
Greater degree of obesity is a well-known risk factor for
the development of uterine cancer [7, 8]. Surgery for uterine
cancer in obese patients can pose significant intra- and
postoperative challenges to the surgeon. Obesity is associated
with a higher rate of conversion of laparoscopic surgery
to laparotomy and a lower completion rate of lymph node
dissection [9].
Although obesity is associated with higher incidence
of uterine cancer and recent studies have reported that
the rate of abdominal hysterectomy performed for benign
indications is increased in obese patients [10], the extent to
which obesity plays a role in the surgical management of
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Figure 1: Flow diagram representing the final determination of all patients in which a hysterectomy was performed among patients with
a diagnosis of uterine cancer, ACS-NSQIP, 2005-2013. ACS-NSQIP: American College of Surgeons-National Surgical Quality Improvement
Program; TAH: total abdominal hysterectomy; TVH: total vaginal hysterectomy; LAVH: laparoscopic assisted vaginal hysterectomy; TLH:
total laparoscopic hysterectomy.

uterine cancer is currently unknown. We hypothesize that,
with increased obesity, the proportion of minimally invasive
surgical approach might decrease. Therefore, in this study, we
explore the association between obesity and surgical route for
the treatment of uterine cancer, and we describe the extent
to which the rate of perioperative complications differs by
obesity status.

2. Materials and Methods
After obtaining exempt status from the University of South
Florida’s institutional review board, we used the American
College of Surgeons-National Surgical Quality Improvement
Program (ACS NSQIP) database from 2005 to 2013 to
conduct a retrospective, cross-sectional analysis of female
patients with uterine cancer who underwent hysterectomy. ACS-NSQIP is a publically available and deidentified
database created as part of a quality improvement initiative
originally developed by the Veterans’ Health Administration
in 1991 and adopted by the American College of Surgeons in
2001 [11, 12]. The database includes more than 450 participating community and academic hospitals nationwide. Data
captured include but are not limited to demographics, comorbidities, laboratory values, and operative variables, as well
as 30-day postoperative outcomes, complications, mortality,
reoperation, and length of stay. Quality improvement and
assurance protocols include routine auditing and the use of
specially trained surgical nurses to record patient variables.

A random 8-day sampling method is used to ensure that a
diverse range of surgical procedures is captured.
In patients aged 18 years or above, we identified women
with uterine cancer using the principal postoperative diagnosis (ICD-9-CM code 182.0, 182.1, or 182.8). We then used
current procedural terminology (CPT) procedure codes to
identify 7,292 surgical cases in which hysterectomy was
performed and then specific codes were used to subclassify
cases as (1) total abdominal hysterectomy (TAH, 58150
and 58200); (2) total vaginal hysterectomy (TVH, 58260,
58262, 58263, 58270, 58275, 58280, 58290, 58291, 58292,
and 58294); (3) laparoscopic assisted vaginal hysterectomy
(LAVH, 58550, 58552, 58553, and 58554); and (4) total laparoscopic hysterectomy (TLH, 58570, 58571, 58572, and 58573).
We excluded 18 cases (0.2%) with CPT codes indicating
more than one surgical route performed. Due to absence
of specific CPT codes, we could not differentiate between
robotically assisted laparoscopic hysterectomies from TLH;
therefore, these groups are combined into a single group
(TLH) (Figure 1).
Body mass index (BMI) was calculated as [(weight in
pounds)/((height in inches)2 ) × 703], and then patients
were classified according to BMI as follows: normal and
underweight (<25), overweight (25–29.9), obese (classes I
and II; 30–39.9), and morbid obesity (class III; ≥40). We
excluded 75 cases (1.0%) for which BMI could not be calculated due to missing information on presurgical weight and
height. Data analyzed included patient age, race/ethnicity,
operative time, length of hospital stay, blood transfusion,
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Figure 2: Frequency and proportion of different types of hysterectomies performed among patients with a diagnosis of uterine cancer, ACS-NSQIP, 2005-2013. TAH: total abdominal hysterectomy; TVH: total vaginal hysterectomy; LAVH: laparoscopic
assisted vaginal hysterectomy; TLH: total laparoscopic hysterectomy.

development of deep venous thrombosis, and development
of surgical infection. Infection types included superficial
surgical site (involving only skin or subcutaneous tissue)
and deep incisional surgical site (involving deep soft tissues).
When data were available (2011 or later), we also captured 30day readmissions.
Descriptive statistics were used to describe the frequency
and temporal trends in surgical approaches in the entire study
population and stratified by patient’s BMI level. Differences
in the distribution of selected patient sociodemographic and
hospital characteristics and in the rates of clinical outcomes
by surgical approach were assessed using either a WilcoxonMann–Whitney test (continuous variables) or chi-square
test (categorical variables). For each hysterectomy route, we
compared the rate of perioperative outcomes across levels of
patient’s BMI. All statistical analyses were conducted using
SAS version 9.4 (SAS Institute, Inc., Cary, NC), using a 5%
type I error rate and two-sided hypothesis tests. STrengthening the Reporting of OBservational studies in Epidemiology
(STROBE) guidelines for reporting observational studies
were followed for this study [13].

3. Results
Between 2005 and 2013, we identified a total of 7,199 uterine
cancer surgical cases managed with hysterectomy and with
documented presurgical weight and height (Figure 1). The
most common route of hysterectomy was TLH (50.4%),
followed by TAH (30.4%), LAVH (16.4%), and TVH (2.8%).
During the study period, we observed a relative increase
in the use of the TLH route (from 15% in 2008 to 64% in
2013) and a concomitant relative decrease in the use of TAH
(from 67% in 2008 to 22% in 2013) (Figure 2). Until 2013,
the proportion of hysterectomies using the LAVH route was
relatively constant over time, as was the small proportion of
surgical cases in which TVH was performed.
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Figure 3: Rates of different types of hysterectomy performed among
patients with a diagnosis of uterine cancer, by patient’s body mass
index, ACS-NSQIP, 2005-2013.

Total laparoscopic hysterectomy was the most performed
procedure regardless of BMI, occurring in 50.9%, 48.9%,
50.4%, and 51.2% of patients with ideal, overweight, obese,
and morbidly obese BMI, respectively (Figure 3). The overall
rate of TAH was 30%; however, the rate tended to be slightly
higher in patients who were morbidly obese (33.6%) relative
to other patients. This increase in the rate of TAH in morbidly
obese patients was at the expense of LAVH (12.4%); the LAVH
rate among the morbidly obese was statistically significantly
lower than the LAVH rate in each of the other BMI categories.
The median patient BMI differed significantly by surgical
approach; patients who underwent TAH had overall higher
BMI (34.0 kg/m2 ) compared to those undergoing TVH (33.1
kg/m2 ), LAVH (32.2 kg/m2 ), and TLH (33.7 kg/m2 ) (Table 1).
Patients undergoing TAH and LAVH were more likely to be
nonwhite than patients undergoing TVH and TLH (𝑝 < 0.01).
The median operative room time was statistically significantly
shorter for TAH (2.2 hours) compared to TLH (2.7 hours).
However, the median length of hospital stay for TAH was
three times longer than TLH, TVH, or LAVH (𝑝 < 0.01). Over
15% of patients who underwent TAH stayed in the hospital
for 6 days or longer, compared to only 1.3% of patients
undergoing TLH (𝑝 < 0.01). The rates of several perioperative
complications were increased significantly in patients who
underwent TAH compared to TLH; these complications
include transfusion (10.3% versus 1.7%) (𝑝 < 0.01), surgical
site infection (7.1% versus 1.7%) (𝑝 < 0.01), and readmission
within 30 days (8.9% versus 3.8%) (𝑝 < 0.01).
Regardless of the route of hysterectomy, patients who
were morbidly obese, obese, or overweight tended to have
statistically significantly longer operation times than patients
who had an ideal BMI (𝑝 < 0.05). Similarly, postoperative
infections, including superficial or deep surgical site infections, were more common in higher BMI categories when
compared with ideal BMI (𝑝 < 0.05), and patients who were
morbidly obese experienced substantially higher rates of any
surgical site or wound infection (6.4%) compared to patients
who had an ideal BMI (1.6%). The 30-day readmission rates
were similar across all BMI categories (Table 2).
The rate of readmission and the rate of a composite infection outcome (including superficial surgical site infection,
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ACS-NSQIP: American College of Surgeons-National Surgical Quality Improvement Program; BMI: body mass index; DVT: deep vein thrombosis.
Unless otherwise indicated, values listed are the frequency and percent.
a
P value from either a Wilcoxon-Mann–Whitney test (continuous variables) or chi-square test (categorical variables).
b
At least 1 unit of packed or whole red blood cells given from the surgical start time up to and including 72 hours postoperatively.
c
Infection that occurs within 30 days after the operation and the infection involves only skin or subcutaneous tissue of the incision.
d
Preoperative evidence of a documented open wound at the time of the principal operative procedure. An open wound is a breach in the integrity of the skin or separation of skin edges and includes open surgical
wounds, with or without cellulitis or purulent exudate. This does not include osteomyelitis or localized abscesses.
e
Infection that occurs within 30 days after the operation and the infection appears to be related to the operation and infection involved deep soft tissues (e.g., fascial and muscle layers) of the incision.
f
Readmission within 30 days was only available beginning in 2011; therefore, the percent provided reflects only the proportion of 2011-13 cases who were readmitted.

BMI (kg/m ), med (Q1-Q3)
BMI (kg/m2 )
<25
25-30
30-40
≥40
Age at admission (years)
<50
50-59
60-69
70-79
≥80
Race/ethnicity
Non-Hispanic white
Non-Hispanic black
Hispanic
Other
Missing
Total operation time (hours), med (Q1-Q3)
Total operation time (hours)
<2
2-3
3-4
4-5
≥5
Length of stay (days), med (Q1-Q3)
Length of stay (days)
0-1
2
3-5
≥6
Bleeding transfusionb
DVT/thrombophlebitis
Superficial surgical site infectionc
Open wound/wound infectiond
Deep incisional surgical site infectione
Any infection listed above
Any adverse outcome listed above
Readmission within 30 daysf

2

Table 1: Distribution of selected patient sociodemographic and hospital characteristics among patients with a diagnosis of uterine cancer and in which a hysterectomy was performed, by
route of hysterectomy, ACS-NSQIP, 2005-2013.
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Table 2: Perioperative outcomes stratified by patient’s body mass index, ACS-NSQIP, 2005-2013.

Characteristic/outcome
Patient age (years)a
Operation time (min)a
Length of hospital stay (days)a
Bleeding transfusionb
DVT/thrombophlebitis
Superficial surgical site infectionc
Open wound/wound infectiond
Deep incisional surgical site infectione
Any infection listed above
Any adverse outcome listed above
Readmission within 30 daysf

Ideal
63 (55-74)
137 (100-189)
1 (1-2)
79 (7.0)
3 (0.3)
11 (1.0)
5 (0.4)
2 (0.2)
18 (1.6)
96 (8.5)
46 (5.0)

BMI classification
Overweight
Obese
65 (57-73)
63 (57-71)
143 (102-193)∗
149 (110-200)∗
1 (1-3)
1 (1-3)
70 (5.0)∗
90 (3.4)∗
11 (0.8)
18 (0.7)
10 (0.7)
53 (2.0)∗
4 (0.3)
10 (0.4)
2 (0.1)
7 (0.3)
16 (1.1)
68 (2.6)
91 (6.5)
167 (6.3)∗
47 (4.1)
101 (4.6)

Morbidly obese
60 (54-65)∗
164 (124-214)∗
1 (1-3)∗
82 (4.1)∗
14 (0.7)
71 (3.5)∗
29 (1.4)∗
28 (1.4)∗
128 (6.4)∗
210 (10.5)
98 (6.0)

ACS NSQIP = American College of Surgeons National Surgical Quality Improvement Program; BMI = body mass index; DVT = deep vein thrombosis.
∗P-value<0.05 from either a Wilcoxon-Mann Whitney test (continuous variables) or chi-square test (categorical variables). For each outcome, three tests are
performed: overweight vs. ideal BMI, obese vs. ideal BMI, morbidly obese vs. ideal BMI.
a
Values presented as median (Q1-Q3); all others are presented as frequency (%).
b
At least 1 unit of packed or whole red blood cells given from the surgical start time up to and including 72 hours postoperatively.
c
Infection that occurs within 30 days after the operation and the infection involves only skin or subcutaneous tissue of the incision.
d
Preoperative evidence of a documented open wound at the time of the principal operative procedure. An open wound is a breach in the integrity of the skin
or separation of skin edges and includes open surgical wounds, with or without cellulitis or purulent exudate. This does not include osteomyelitis or localized
abscesses.
e
Infection that occurs within 30 days after the operation and the infection appears to be related to the operation and infection involved deep soft tissues (e.g.,
fascial and muscle layers) of the incision.
f
Readmission within 30 days was only available beginning in 2011; therefore, the percent provided reflects only the proportion of 2011-13 cases who were
readmitted.

open wound/wound infection, and deep incisional surgical
site infection) within 30 days were significantly lower for TLH
and LAVH compared to TAH in all BMI subgroups except for
the overweight group (Supplemental Tables S1-S4).
In comparing perioperative outcomes of TLH stratified
by patient’s BMI category, it was noted that increasing degree
of obesity was associated with longer operative time. The
mean operation time in patients of ideal weight (145 min) was
shorter compared to overweight, obese, and morbidly obese
women (159, 158, and 171 minutes, resp., 𝑝 < 0.05). Also, the
rate of open surgical wound or wound infection was higher
in the morbidly obese group (1.3%) compared to ideal weight
patients (0.2%) (𝑝 < 0.05). All other perioperative outcomes
were not statistically significantly different across BMI levels
(Table 3).

4. Discussion
In this study, using the ACS-NSQIP database, TLH (including
conventional or robotically assisted) was found to be the
most frequently chosen route for hysterectomy for surgical
management of patients with uterine cancer. Performance
of TLH increased from 16.5% in 2008 to 64.1% in 2013.
We also found that TLH is the most commonly chosen
route regardless of the degree of obesity. Despite increased
operative time compared to abdominal hysterectomy, the
minimally invasive approach provided better perioperative
outcomes manifesting in decreased length of hospital stay
and decreased rates of transfusion, surgical site infection,

and readmission within 30 days. The utilization of TLH was
not negatively impacted by the degree of obesity, despite the
increase in operative time and surgical infection.
The results from current study are consistent with data
from the SEER database, which showed that performance
of minimally invasive hysterectomy has increased from
9.3% in 2006 to 61.7% in 2011 [14]. Minimally invasive
surgery improved outcomes including decreased hospital
stay, increased patient quality of life, consistency with patient
preference, and enhanced cosmesis [15]. These factors have
been considered as important drivers of cost and efficiency
in the era of the Affordable Care Act [16].
Compared to other routes, TAH rates among patients
with uterine cancer were higher in morbidly obese women
compared to women with lower BMI levels. This might be
explained by the increased and persistent technical challenges
encountered by surgeons during minimally invasive surgery
in patients with higher degrees of obesity [17]. Excessive adiposity poses several challenges to the surgical team, including
poor patient tolerance to Trendelenburg positioning and
positive intra-abdominal pressure, surgeons’ fatigue, and the
inability to correctly expose and develop the anatomical
spaces [18].
On the other hand, TAH was found to be associated with
an increased risk for perioperative complications when compared with other surgical routes. This is reflected by longer
hospital stay, higher rates of surgical sites infections, and
higher 30-day readmission rates. Since higher perioperative
complications can compromise overall survival and success of
adjuvant therapy, it is critical to take active measures to avoid
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Table 3: Perioperative outcomes among uterine cancer patients undergoing total laparoscopic hysterectomy, stratified by patient’s body mass
index, ACS-NSQIP, 2005-2013.
Characteristic/outcome
Patient age (years)a
Operation time (min)a
Length of hospital stay (days)a
Bleeding transfusionb
DVT/thrombophlebitis
Superficial surgical site infectionc
Open wound/wound infectiond
Deep incisional surgical site infectione
Any infection listed above
Any adverse outcome listed above
Readmission within 30 daysf

Ideal
63 (55-72)
145 (113-194)
1 (1-1)
16 (2.8)
0 (0.0)
3 (0.5)
1 (0.2)
0 (0.0)
4 (0.7)
20 (3.5)
15 (2.8)

BMI classification
Overweight
Obese
65 (57-72)∗
63 (57-70)
159 (119-205)∗
158 (120-206)∗
1 (1-1)
1 (1-1)
12 (1.7)
18 (1.3)∗
4 (0.6)
6 (0.4)
4 (0.6)
13 (1.0)
1 (0.1)
7 (0.5)
1 (0.1)
2 (0.1)
6 (0.9)
22 (1.6)
20 (2.9)
44 (3.3)
23 (3.6)
50 (3.9)

Morbidly obese
60 (54-66)∗
171 (134-218)∗
1 (1-1)∗
14 (1.4)
7 (0.7)
13 (1.3)
13 (1.3)∗
5 (0.5)
31 (3.0)∗
51 (5.0)
41 (4.2)

ACS NSQIP = American College of Surgeons National Surgical Quality Improvement Program; BMI = body mass index; DVT = deep vein thrombosis.
∗P-value<0.05 from either a Wilcoxon-Mann Whitney test (continuous variables) or chi-square test (categorical variables). For each outcome, three tests are
performed: overweight vs. ideal BMI, obese vs. ideal BMI, morbidly obese vs. ideal BMI.
a
Values presented as median (Q1-Q3); all others are presented as frequency (%).
b
At least 1 unit of packed or whole red blood cells given from the surgical start time up to and including 72 hours postoperatively.
c
Infection that occurs within 30 days after the operation and the infection involves only skin or subcutaneous tissue of the incision.
d
Preoperative evidence of a documented open wound at the time of the principal operative procedure. An open wound is a breach in the integrity of the skin
or separation of skin edges and includes open surgical wounds, with or without cellulitis or purulent exudate. This does not include osteomyelitis or localized
abscesses.
e
Infection that occurs within 30 days after the operation and the infection appears to be related to the operation and infection involved deep soft tissues (e.g.,
fascial and muscle layers) of the incision.
f
Readmission within 30 days was only available beginning in 2011; therefore, the percent provided reflects only the proportion of 2011-13 cases who were
readmitted.

or reduce the incidence of such complications [19]. With
accumulating experience and increased training in minimally
invasive surgeries, including robotically assisted procedures,
the adoption of such techniques is likely to increase in the
future; we suspect a concomitant improvement in perioperative outcomes in patients with uterine cancer [5].
In cases where pelvic lymph node dissection is performed, the preferred route for hysterectomy is either abdominal or laparoscopic. The utilization of TVH for uterine cancer
surgery is controversial and the utility of nodal dissection
in uterine cancer patients lacks a consensus opinion [20].
The role of TVH in uterine cancer depends on the type
of the tumor, the stage of tumor, BMI, and presence of
comorbidities. For stage I grade I uterine cancer, TVH may
be reasonable, especially if CA-125 level <20 U/mL because of
the low likelihood of extrauterine tumor invasion [21]. TVH
utilization is limited in more advanced uterine cancer due to
the limited ability to complete cancer staging.
In comparison with higher degrees of obesity, ideal body
weight was found to be associated with the most favorable
perioperative outcomes. This is supported by other studies
showing obesity to be associated with increased complication
rates in elective hysterectomy procedures, independent of the
surgical route. Morbid obesity was found to be associated
with increased conversion of laparoscopic surgery to laparotomy and less complete lymph node dissection [19, 22, 23].
Obesity is now considered as a pandemic with increasing
prevalence [24]. It has been shown that patients who are obese
experience some of the greatest differential benefits from

minimally invasive techniques [10]. Obesity increased the risk
of unintended conversion to laparotomy, where patients with
BMI >40 have 4-fold increase in the conversion rate [18].
The ACS-NSQIP database that was used in this study
represents a major strength due to its multi-institutional
nature and is widely considered to be accurate, reproducible,
and reliable. Data are collected by specially trained surgical
clinical nurse reviewers who collect more than 100 clinical
variables, including preoperative risk factors, intraoperative
variables, and 30-day postoperative mortality and morbidity
outcomes for patients undergoing major surgical procedures
[25].
A weakness of this study is its observational nature.
Although clinical trials can be the best research path to
delineate optimum surgical approach for uterine cancer
in morbidly obese patients, observational studies can be
invaluable tool for hypothesis generation and prediction of
patients who are at higher risk of complication of a certain
therapeutic approach. Another weakness of the study is the
fact that it lacked data on patient survival and its association
with BMI categories and the inability to differentiate between
conventional laparoscopic and robotic procedures. The data
in the ACS-NSQIP are only from participating hospitals
and, despite being distributed throughout USA, they do
not collectively represent a statistically selected nationally
representative sample. This study also lacks data regarding
lymph node dissection; traditionally obesity is thought to
be associated with less complete lymph node dissection;
interestingly, in a study by Uccella et al, it was found that the
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number of lymph nodes removed was not affected by BMI
[18]. TLH is currently the most commonly performed route
for hysterectomy for patients with uterine cancer, regardless
of the degree of obesity. Other confounding variables including surgical experience, hospital to hospital variation, and
ethnicity could not be controlled for in this analysis.
Obesity poses an important challenge for the surgeon
in selecting the surgical modality that balances between
the technical difficultly and obtaining the best perioperative
surgical outcomes.
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